Independent diagnostic utility of CD20, CD200, CD43 and CD45 in chronic lymphocytic leukaemia

References

• Eichhorst B, Robak T, Montserrat E, et al. Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl. 5):v78–84.
   PubMed Web of Science ®Google Scholar
• Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the international workshop on chronic lymphocytic leukemia updating the national cancer Institute-Working group 1996 guidelines. Blood. 2008;111(12):5446–5456.
   PubMed Web of Science ®Google Scholar
• Oscier D, Dearden C, Eren E, et al. Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. Br J Haematol. 2012;159(5):541–564.
   PubMed Web of Science ®Google Scholar
• Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8(10):1640–1645.
   PubMed Web of Science ®Google Scholar
• Moreau EJ, Matutes E, A’Hern RP, et al. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol. 1997;108(4):378–382.
   PubMed Web of Science ®Google Scholar
• Hoffmann J, Rother M, Kaiser U, et al. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping. Cytometry B Clin Cytom. 2020;98(6):476–482.
   PubMed Web of Science ®Google Scholar
• Kohnke T, Wittmann VK, Sauter D, et al. Proposal for a novel scoring system for the diagnosis of CLL. Blood. 2013; 122(21):4150–4150.
   Google Scholar
• Rawstron AC, Kreuzer K-A, Soosapilla A, et al. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European research initiative on CLL (ERIC) & European society for clinical cell analysis (ESCCA) harmonisation project. Cytometry. 2018;94(1):121–128.
   PubMedGoogle Scholar
• Maljaei SH, Asvadi-E-Kermani I, Eivazi-E-Ziaei J, et al. Usefulness of CD45 density in the diagnosis of B-cell chronic lymphoproliferative disorders. Indian J Med Sci. 2005;59(5):187–194.
   PubMedGoogle Scholar
• Rizzo D, Lotay A, Gachard N, et al. Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival. Am J Hematol. 2013;88(9):747–753.
   PubMed Web of Science ®Google Scholar
• Lopez-Matas M, Rodriguez-Justo M, Morilla R, et al. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia. Haematologica. 2000;85(11):1140–1145.
   PubMed Web of Science ®Google Scholar
• Hu Z, Sun Y, Schlette EJ, et al. CD200 expression in MCL identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course. Mod Pathol. 2018;31(2):327–336.
   PubMed Web of Science ®Google Scholar
• Treasure J, Lane A, Jones DB, et al. CD43 expression in B cell lymphoma. J Clin Pathol. 1992;45(11):1018–1022.
   PubMed Web of Science ®Google Scholar
• Sorigue M, Juncà J, Sarrate E, et al. Expression of CD43 in chronic lymphoproliferative leukemias. Cytometry B Clin Cytom. 2018;94(1):136–142.
   PubMed Web of Science ®Google Scholar
• DiRaimondo F, Albitar M, Huh Y, et al. The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease. Cancer. 2002;94(6):1721–1730.
   PubMed Web of Science ®Google Scholar
• Falay M, Afacan Öztürk B, Güneş K, et al. The role of CD200 and CD43 expression in differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma. Turk J Haematol. 2018;35(2):94–98.
   PubMed Web of Science ®Google Scholar
• Mora A, Bosch R, Cuellar C, et al. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia. Cytometry. 2019;96(2):143–148.
   PubMedGoogle Scholar
• Almasri NM, Duque RE, Iturraspe J, et al. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol. 1992;40(4):259–263.
   PubMed Web of Science ®Google Scholar
• Delgado J, Matutes E, Morilla AM, et al. Diagnostic significance of CD20 and FMC7 expression in B-cell disorders. Am J Clin Pathol. 2003;120(5):754–759.
   PubMed Web of Science ®Google Scholar
• Ting YS, Smith SABC, Brown DA, et al. CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry. Int J Lab Hematol. 2018;40(5):533–539.
   PubMed Web of Science ®Google Scholar
• Palumbo GA, Parrinello N, Fargione G, et al. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia . Leuk Res. 2009;33(9):1212–1216.
   PubMed Web of Science ®Google Scholar
• Sandes AF, de Lourdes Chauffaille M, Oliveira CRMC, et al. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry. Cytometry B Clin Cytom. 2014;86(2):98–105.
   PubMed Web of Science ®Google Scholar
• Mitrovic Z, Iqbal J, Fu K, et al. CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma. Br J Haematol. 2013;162(1):87–92.
   PubMed Web of Science ®Google Scholar
• Subramanian PG, Gadage VS, Kumar A, et al. Diagnostic utility of CD200 and CD43 co-expression by flow cytometry in differentiating chronic lymphocytic lymphoma from other of mature B cell non Hodgkin’s lymphoma. Blood. 2010;116(21):4615–4615.
   Google Scholar
• Carulli G, Cannizzo E, Zucca A, et al. CD45 expression in low-grade B-cell non-Hodgkin’s lymphomas. Leuk Res. 2008;32(2):263–267.
   PubMed Web of Science ®Google Scholar